{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:47:41Z","timestamp":1754164061168,"version":"3.41.2"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.lungcan.2025.108574","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:23:06Z","timestamp":1746321786000},"page":"108574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of thyroid radiation dose with thyroid dysfunction in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy followed by maintenance immunotherapy"],"prefix":"10.1016","volume":"204","author":[{"given":"Gowoon","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong In","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Geol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Chul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lungcan.2025.108574_b0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108574_b0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108574_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40842-018-0073-4","article-title":"Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports","volume":"5","author":"Tan","year":"2019","journal-title":"Clin Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108574_b0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","article-title":"Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies","volume":"13","author":"Byun","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.lungcan.2025.108574_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.798253","article-title":"Immunotherapy-associated hypothyroidism: comparison of the pre-existing with de-novo hypothyroidism","volume":"13","author":"Kristan","year":"2022","journal-title":"Front Endocrinol (lausanne)."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108574_b0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2025.108574_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2019.05.015","article-title":"Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders","volume":"141","author":"Jannin","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108574_b0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/a-0843-3366","article-title":"A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors","volume":"51","author":"de Filette","year":"2019","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108574_b0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijrobp.2020.12.047","article-title":"Risk of hypothyroidism in women after radiation therapy for breast cancer","volume":"110","author":"Choi","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108574_b0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0360-3016(93)E0112-J","article-title":"Thyroid dysfunction following radiotherapy for head and neck cancer","volume":"31","author":"Turner","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108574_b0055","article-title":"Radiation-induced hypothyroidism after treatment of head and neck cancer","volume":"63","author":"Feen","year":"2016","journal-title":"Dan. Med. J."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108574_b0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199108293250902","article-title":"Thyroid diseases after treatment of Hodgkin's disease","volume":"325","author":"Hancock","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108574_b0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lungcan.2022.02.003","article-title":"Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial","volume":"166","author":"Naidoo","year":"2022","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108574_b0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MED.0000000000000089","article-title":"Psychiatric and cognitive manifestations of hypothyroidism","volume":"21","author":"Samuels","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"13","key":"10.1016\/j.lungcan.2025.108574_b0075","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/heartjnl-2018-314528","article-title":"Pericardial diseases in patients with hypothyroidism","volume":"105","author":"Chahine","year":"2019","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.lungcan.2025.108574_b0080","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamaoncol.2019.0393","article-title":"Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108574_b0085","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.ijrobp.2010.09.054","article-title":"Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma","volume":"82","author":"Cella","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2025.108574_b0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1748-717X-9-104","article-title":"V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck","volume":"9","author":"Akgun","year":"2014","journal-title":"Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108574_b0095","first-page":"146","article-title":"Hypothyroidism after radiotherapy to the neck","volume":"64","author":"Yoden","year":"2004","journal-title":"Nippon Igaku Hoshasen Gakkai Zasshi"},{"issue":"3","key":"10.1016\/j.lungcan.2025.108574_b0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meddos.2017.03.003","article-title":"Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases","volume":"42","author":"Kanyilmaz","year":"2017","journal-title":"Med. Dosim."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108574_b0105","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4103\/0973-1482.167613","article-title":"Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study","volume":"11","author":"Tunio","year":"2015","journal-title":"J. Cancer Res. Ther."},{"issue":"1046","key":"10.1016\/j.lungcan.2025.108574_b0110","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140654","article-title":"Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique","volume":"88","author":"Lu","year":"2015","journal-title":"Br. J. Radiol."},{"issue":"6","key":"10.1016\/j.lungcan.2025.108574_b0115","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3892\/ol.2014.2039","article-title":"Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis","volume":"7","author":"Kim","year":"2014","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108574_b0120","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.3390\/curroncol28050283","article-title":"Safety of immune checkpoint inhibitors in elderly patients: an observational study","volume":"28","author":"Paderi","year":"2021","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108574_b0125","article-title":"Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors","volume":"4","author":"Bukhari","year":"2023","journal-title":"Cell Rep. Med."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225004660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:21:52Z","timestamp":1753993312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225004660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":25,"alternative-id":["S0169500225004660"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108574","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of thyroid radiation dose with thyroid dysfunction in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy followed by maintenance immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108574"}}